Use of oral chemotherapeutic agent, chlorambucil, as palliative treatment of thryoid adenocarcinoma in a golden-headed lion tamarin (Leontopithecus chrysomelas)

This case report describes the use of chlorambucil in a 7.5-year-old golden-headed lion tamarin (Leontopithecus chrysomelas) as palliative therapy for thyroid adenocarcinoma. Treatment was initiated at 0.1 mg/kg orally once daily. No physical abnormalities or substantial changes in complete blood cell counts and thyroid hormone levels from serial samples were detected.

Automated summary

This case report illustrates the use of chlorambucil as palliative therapy for thyroid adenocarcinoma in a 7.5-year-old golden-headed lion tamarin. No physical abnormalities or significant changes in blood cell counts and thyroid hormone levels were observed during treatment.